US Patent Issued to Cornell University on Aug. 25 for "Engineered phospholipase D mutants, methods of making engineered phospholipase D mutants, and uses thereof" (New York Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,716,080, issued on Aug. 25, was assigned to Cornell University (Ithaca, N.Y.).

"Engineered phospholipase D mutants, methods of making engineered phospholipase D mutants, and uses thereof" was invented by Jeremy Baskin (Ithaca, N.Y.) and Reika Tei (Ithaca, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Engineered phospholipase D mutants are described herein. Also described herein are methods of making engineered phospholipase D mutants. Additionally, methods of using engineered phospholipase D mutants are described."

The patent was filed on Dec. 6, 2022, under Application No. 18/716,659.

*For further information, including images, charts and table...